United Kingdom· GB-APID-11491211000001106
Elaprase 6mg/3ml concentrate for solution for infusion vials
A idursulfase product containing idursulfase, registered in United Kingdom by Takeda UK Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Idursulfase is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AB09 (idursulfase), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Idursulfase · ATC A16AB09
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Idursulfase
- Manufacturer
- Takeda UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- A16AB09
- ATC class
- Idursulfase
- Defined daily dose
- 5 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin7350006499210
- gtin05060147026931
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Idursulfase in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaELAPRASETakeda Pharmaceuticals International AG Ireland Branch, Dublin
- CanadaELAPRASETAKEDA CANADA INC
- SwitzerlandElaprase
- SpainELAPRASE 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONTakeda Pharmaceuticals International Ag Ireland Branch
- FinlandElapraseTakeda Pharmaceuticals International AG Ireland Branch
- FranceELAPRASE 2 mg/ml, solution à diluer pour perfusionTAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- IrelandElaprase 2 mg/ml concentrate for solution for infusionTakeda Pharmaceuticals International AG Ireland Branch
- IcelandElapraseTakeda Pharmaceuticals International AG Ireland Branch
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Elaprase
- Liechtenstein · Elaprase
- Norway · Elaprase
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8a67f129-a62f-4532-b1fc-b969a75c0468 GET /v1/drugs/8a67f129-a62f-4532-b1fc-b969a75c0468?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "11491211000001106",
"desc": "Elaprase 6mg/3ml concentrate for solution for infusion vials (Takeda UK Ltd)",
"form": "Solution for infusion",
"vpid": "35895311000001106",
"source": "dmd",
"vtm_id": "776303000",
"strength": "2 mg",
"substance": "Idursulfase",
"ingredient": "Idursulfase",
"supplier_code": "3811601000001107"
}See everything about idursulfase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.